Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.39 |
| ▸ | RAC2 | P15153 | 1/20 | 0.38 |
| ▸ | RAC3 | P60763 | 1/20 | 0.38 |
| ▸ | CDC42 | P60953 | 1/20 | 0.38 |
| ▸ | RAC1 | P63000 | 1/20 | 0.38 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20595940 | 1.00 | L3MBTL1 (0.50) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL20596461 | 1.00 | L3MBTL1 (0.50) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL20596613 | 1.00 | L3MBTL1 (0.50) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL22143369 | 0.95 | ATM (0.44) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL22143352 | 0.95 | ATM (0.44) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL20596342 | 0.92 | L3MBTL1 (0.45) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL21416199 | 0.92 | L3MBTL1 (0.50) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL20161061 | 0.91 | L3MBTL1 (0.52) | L3MBTL1ATMKDM4EKMT2ARAC2 | |
| SCHEMBL13554141 | 0.91 | L3MBTL1 (0.56) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL13554142 | 0.91 | L3MBTL1 (0.56) | L3MBTL1ATMKDM4EPTGER4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018237385-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2018-12-27 | — | — | WO | claimed |
| US-11584739-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-02-21 | — | — | US | disclosed |
| US-11584739-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-02-21 | — | — | US | disclosed |
| US-20210210696-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NITROGEN-CONTAINING COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
| US-20200115364-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2020-04-16 | — | — | US | disclosed |
| WO-2018237385-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2018-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115364-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, CLTB, CYBA | L3MBTL1 575/4885ATM 1853/4885KDM4E 3779/4885 |
| US-11584739-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, CLTB, CYBA | L3MBTL1 575/4885ATM 1853/4885KDM4E 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.